Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    20219963 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Pre-Clinical (Alzheimers) Diagnosis PCD = Optimum Outcomes OO
Condition: Alzheimer Disease
Interventions: Drug: roflumilast;   Biological: ustekinumab
2 Unknown  Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IV
Condition: Mild Cognitive Impairment
Interventions: Behavioral: APOE genotype disclosure and Alzheimer's disease risk disclosure;   Behavioral: Alzheimer's disease risk disclosure

Indicates status has not been verified in more than two years